Company Filing History:
Years Active: 1998-1999
Title: Marion Kursawe: Innovator in Transdermal Therapeutic Systems
Introduction
Marion Kursawe is a notable inventor based in Andernach, Germany. She has made significant contributions to the field of transdermal therapeutic systems, particularly focusing on the active substance 17-.beta.-estradiol. With a total of 2 patents to her name, her work has the potential to impact the medical and pharmaceutical industries.
Latest Patents
Kursawe's latest patents include a process for the production of a transdermal therapeutic system and a transdermal therapeutic system comprising the active substance. The first patent describes a process that involves a laminated structure positioned on a backing layer that is impermeable to active substances and moisture. This system includes one or more matrix layers and optionally an adhesive layer, with at least one layer containing anhydrous 17-.beta.-estradiol in crystalline form. The second patent outlines a similar transdermal therapeutic system that also incorporates the active substance 17-.beta.-estradiol, emphasizing its laminated structure and the inclusion of matrix and adhesive layers.
Career Highlights
Kursawe is currently associated with LTS Lohmann Therapie-Systeme GmbH & Co. KG, where she continues to innovate in her field. Her work is characterized by a commitment to developing effective therapeutic systems that enhance drug delivery methods.
Collaborations
Throughout her career, Kursawe has collaborated with notable colleagues, including Michael Horstmann and Horst Dzekan. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Marion Kursawe's contributions to the field of transdermal therapeutic systems highlight her innovative spirit and dedication to improving healthcare solutions. Her patents reflect a significant advancement in drug delivery technology, showcasing her role as a leading inventor in this area.